To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.

 
 

Description

Melanoma is a prevalent type of skin cancer found in melanin-producing cells. Current melanoma treatment methods include chemotherapy medications: Ipilimumab (Yervoy®), Nivolumab (Opdivo®), and Dabrafenib (Tafinlar®). However, in the past 20 years, essential oils (EOs) have been found to prevent cancerous growth and symptoms as a potential alternative therapy. The purpose of this comprehensive and systematic review is to discuss the utilization of essential oils that possess therapeutics effects on melanoma cells. These EOs can be considered as a possible adjuvant or alternative therapy to enhance treatment efficiency and quality of life in melanoma patients.

Disciplines

Scholarship of Teaching and Learning

Document Type

Event

Additional Files
A Cross-Sectional Analysis of Published Studies for Essential Oils in the Treatment of Melanoma- Abstract.pdf (61 kB)
This is the accompanying abstract along with the poster for A Cross-Sectional Analysis of Published Studies for Essential Oils in the Treatment of Melanoma.
Download

Share

COinS
 

S11: A Cross-sectional Analysis of Published Studies for Essential Oils in the Treatment of Melanoma

Melanoma is a prevalent type of skin cancer found in melanin-producing cells. Current melanoma treatment methods include chemotherapy medications: Ipilimumab (Yervoy®), Nivolumab (Opdivo®), and Dabrafenib (Tafinlar®). However, in the past 20 years, essential oils (EOs) have been found to prevent cancerous growth and symptoms as a potential alternative therapy. The purpose of this comprehensive and systematic review is to discuss the utilization of essential oils that possess therapeutics effects on melanoma cells. These EOs can be considered as a possible adjuvant or alternative therapy to enhance treatment efficiency and quality of life in melanoma patients.